Pathfinder Cell Therapy, Inc.
PFND
$0.00
$0.000.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.00K | -- | 21.00K | 26.00K | 23.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.00K | 18.00K | 33.00K | 47.00K | 14.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.00K | 18.00K | 54.00K | 73.00K | 37.00K |
|
|
|||||
| Total Current Assets | 9.00K | 18.00K | 54.00K | 73.00K | 37.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 30.00K | 31.00K | 32.00K | 33.00K | 33.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.00K | 49.00K | 86.00K | 106.00K | 70.00K |
|
|
|||||
| Total Accounts Payable | 326.00K | 323.00K | 279.00K | 229.00K | 188.00K |
| Total Accrued Expenses | 1.03M | 936.00K | 872.00K | 837.00K | 728.00K |
| Short-term Debt | 5.41M | 5.23M | 5.15M | 4.98M | 4.80M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.77M | 6.49M | 6.31M | 6.05M | 5.72M |
|
|
|||||
| Total Current Liabilities | 6.77M | 6.49M | 6.31M | 6.05M | 5.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 5.41M | 5.23M | 5.15M | 4.98M | 4.80M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.77M | 6.49M | 6.31M | 6.05M | 5.72M |
|
|
|||||
| Common Stock & APIC | 12.50M | 12.50M | 12.50M | 12.50M | 12.50M |
| Retained Earnings | -19.23M | -18.94M | -18.72M | -18.44M | -18.15M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.73M | -6.44M | -6.22M | -5.94M | -5.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.73M | -6.44M | -6.22M | -5.94M | -5.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.73M | -6.44M | -6.22M | -5.94M | -5.65M |
|
|
|||||